Literature DB >> 22537456

Serum soluble death receptor 5 concentration in patients with chronic hepatitis B is associated with liver damage and viral antigen level.

Juan Du1, Lei Wang, Jianjun Han, Lifen Gao, Chunhong Ma, Xiaohong Liang.   

Abstract

OBJECTIVES: To measure the levels of serum soluble death receptor 5 (sDR5) in patients with hepatitis B. DESIGN AND METHODS: sDR5 concentration in 60 HBV infected patients and 30 healthy volunteers were measured by ELISA.
RESULTS: sDR5 concentration in the HBV infected patients was decreased and correlated with serum ALT, Tbil level, albumin/globulin ratio and HBV antigen level.
CONCLUSIONS: Decreased serum sDR5 is associated with high level of liver damage and inhibited HBV antigen expression.
Copyright © 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22537456     DOI: 10.1016/j.clinbiochem.2012.04.007

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  2 in total

1.  Clinical significance of serum soluble death receptor 5 concentration in locally advanced non-small cell lung cancer patients.

Authors:  Xinshuang Yu; Juan DU; Chunjuan Zhai; Jiandong Zhang; Guangyun Li; Wei Dong; Deguo Xu; Fengjun Liu; Zhen Liu; Yuan Tian; Meijuan Song; Ying Ju; Baosheng Li
Journal:  Oncol Lett       Date:  2014-06-11       Impact factor: 2.967

2.  Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.

Authors:  Yanqiu Wu; Yongchun Shen; Junlong Zhang; Chun Wan; Tao Wang; Dan Xu; Ting Yang; Fuqiang Wen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.